Fiaschi A I, Cozzolino A, Ruggiero G, Giorgi G
Department of Pharmacology G. Segre, Faculty of Medicine and Surgery, University of Siena, Siena, Italy.
Eur Rev Med Pharmacol Sci. 2005 Nov-Dec;9(6):361-7.
Oral squamous cell carcinoma is one of the most common cancers in the world. Reactive oxygen species are postulated to be involved in neoplastic transformation. The antioxidant defence system limits cell injury induced by reactive oxygen species. Oxidative stress occurs when there is an imbalance between the production of reactive oxygen species and a cell's oxidant capacity or when there is a decrease in this capacity. This stress may cause mutagenesis, cytotoxicity and changes in gene expression that initiate or promote carcinogenesis.
The present study was conducted to investigate whether tumor tissue and blood of patients with oral squamous cell carcinoma have altered antioxidants levels.
Levels of antioxidants such as reduced glutathione (GSH) and ascorbic acid (AA) and the activities of antioxidant enzymes superoxide dismutase (SOD), glutathione peroxidase (GPx), glutatione reductase (GR), were estimated in the tumor tissue and blood of 18 oral squamous cell carcinoma patients and in 20 healthy subjects as control.
Significantly increased levels of GSH, GPx, GR and AA and significantly decreased activity of SOD were observed in tumor tissue (p < 0.001) and in tumor-free tissue of oral cancer patients as compared with healthy subjects. In contrast, decrease in antioxidants (GSH, GPx, GR and AA p < 0.001, SOD p < 0.05 respectively) was observed in the blood of oral cancer patients, as compared with healthy subjects.
The low levels of antioxidants in the blood of oral cancer patients may be due to their increased utilization to scavenge lipid peroxides as well as their sequestration by tumor cells. The enhanced antioxidant capacities in tumor tissues can make them less susceptible to oxidative stress, conferring a selective growth advantage on tumor cells. These finding suggest that normalization of the levels of these antioxidants might be used to reduce oral tumor malignancy.
口腔鳞状细胞癌是世界上最常见的癌症之一。活性氧被认为参与肿瘤转化。抗氧化防御系统限制活性氧诱导的细胞损伤。当活性氧的产生与细胞的抗氧化能力之间失衡或这种能力下降时,就会发生氧化应激。这种应激可能导致诱变、细胞毒性和基因表达变化,从而引发或促进癌症发生。
本研究旨在调查口腔鳞状细胞癌患者的肿瘤组织和血液中抗氧化剂水平是否发生改变。
在18例口腔鳞状细胞癌患者的肿瘤组织和血液以及20例健康受试者作为对照中,估计了抗氧化剂如还原型谷胱甘肽(GSH)和抗坏血酸(AA)的水平以及抗氧化酶超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GPx)、谷胱甘肽还原酶(GR)的活性。
与健康受试者相比,在肿瘤组织以及口腔癌患者的无肿瘤组织中观察到GSH、GPx、GR和AA水平显著升高,SOD活性显著降低(p < 0.001)。相比之下,与健康受试者相比,口腔癌患者血液中的抗氧化剂(GSH、GPx、GR和AA分别为p < 0.001,SOD为p < 0.05)减少。
口腔癌患者血液中抗氧化剂水平较低可能是由于它们用于清除脂质过氧化物的利用率增加以及被肿瘤细胞隔离。肿瘤组织中增强的抗氧化能力可使其对氧化应激的敏感性降低,赋予肿瘤细胞选择性生长优势。这些发现表明,这些抗氧化剂水平的正常化可能用于降低口腔肿瘤的恶性程度。